PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Osong Public Health and Research Perspectives10.24171/j.phrp.2017.8.3.04201783179-184Long-term Treatment with Anti-platelet Agents for Collagen-induced Arthritis Improves Radiological FindingsChan Kim, Toyou Kim, Jihyung Yoo, Dong-Hyuk Sheen, Sang Kwang Lee, Eun-Hye Choi, Tong Jin Chun, Seong-wook Kang, Seung-Cheol Shim, Mi-Kyoung Limhttp://pdf.medrang.co.kr/PHRP/2017/008/PHRP008-03-04.pdf, http://pdf.medrang.co.kr/PHRP/2017/008/PHRP008-03-04.pdf
Arthritis & Rheumatism10.1002/art.34497201264103189-3198Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatmentsFabien Dépis, Eric Hatterer, Céline Lamacchia, Jean-Marc Waldburger, Cem Gabay, Walter Reith, Marie Kosco-Vilbois, Yann Deanhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.34497, https://onlinelibrary.wiley.com/doi/full/10.1002/art.34497
Arthritis & Rheumatism10.1002/art.23363200858S2S110-S122Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFα, anti-IL-1α/β and IL-1Rahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.23363, https://onlinelibrary.wiley.com/doi/full/10.1002/art.23363
Arthritis & Rheumatism10.1002/art.17803303271990333451-452The effect of long-term sulfasalazine therapy on type II collagen-induced arthritis in ratsB. Bannwarth, P. Gillet, P. Fener, P. Netter, A. Gaucherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780330327, https://onlinelibrary.wiley.com/doi/full/10.1002/art.1780330327
Clinical & Experimental Immunology10.1046/j.1365-2249.1998.00638.x1998113192-95Bystander suppression of murine collagen-induced arthritis by long-term nasal administration of a self type II collagen peptideŞ. Bayrak, N. A. Mitchisonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2249.1998.00638.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2249.1998.00638.x, http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2249.1998.00638.x/fullpdf
Agents and Actions10.1007/bf019728271989273-4378-379Systemic administration of TIMP in the treatment of collagen-induced arthritis in miceD. F. Carmichael, G. P. Stricklin, J. M. Stuarthttp://link.springer.com/content/pdf/10.1007/BF01972827.pdf, http://link.springer.com/article/10.1007/BF01972827/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF01972827
Clinical and Developmental Immunology10.1155/2013/296031201320131-7Dexamethasone Preconditioning Improves the Response of Collagen-Induced Arthritis to Treatment with Short-Term Lipopolysaccharide-Stimulated Collagen-Loaded Dendritic CellsCorina Peña, David Gárate, Juan Contreras-Levicoy, Octavio Aravena, Diego Catalán, Juan C. Aguillónhttp://downloads.hindawi.com/journals/jir/2013/296031.pdf, http://downloads.hindawi.com/journals/jir/2013/296031.xml, http://downloads.hindawi.com/journals/jir/2013/296031.pdf
InPharma10.1007/bf03307884198862817-7Long-term Methotrexate Improves Symptoms of Rheumatoid Arthritishttp://link.springer.com/content/pdf/10.1007/BF03307884.pdf, http://link.springer.com/article/10.1007/BF03307884/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF03307884
European Journal of Immunology10.1002/eji.183021053619912151327-1330Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: suppression of arthritis without reduction of anti-type II collagen autoantibody levelsTom J. Goldschmidt, Rikard Holmdahlhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.1830210536, https://onlinelibrary.wiley.com/doi/full/10.1002/eji.1830210536
Agents and Actions10.1007/bf019712371986195-6318-319Suppression of collagen-induced arthritis with pergastrically or intravenously administered type II collagenH. S. G. Thompson, N. A. Staineshttp://link.springer.com/content/pdf/10.1007/BF01971237.pdf, http://link.springer.com/article/10.1007/BF01971237/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF01971237